So there not an excipient supplier ! Perhaps they should be if Ashland can sell 10 tons of product having been sold the ave furniture for peanuts ! Not bad cash flow .
The ave patent protection attribute seems of little value considering the plethora of past partners .
Unfortunately Paul's comments unravel due to the Monash study instigated by ave illustrating tpm performance against various excipients including tpgs where tpm showed no statistical significance when compared with tpgs . Why did they bother ?
But the game today is cannabinoids and tpgs is solubilizer of choice with several manufacturers selling commercial products .
Is Paul still suggesting tpgs irrelevant ?
Paul knows the answer well before any comparative study . Similar performance but tpm is too expensive . How could they ever compete with giants like BASF etc ?
So there not an excipient supplier ! Perhaps they should be if...
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.338M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 34 | 44954072 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 46237350 | 29 |
View Market Depth
| Last trade - 11.42am 27/09/2024 (20 minute delay) ? |
| AVE (ASX) Chart |
Day chart unavailable